Welcome

 

VelaLabs is a world-wide acting, GMP-certified contract laboratory that offers in-depth analytical characterisation services for proteins (Biopharmaceuticals, Biologics and Biosimilars).

Combining a focused, customer - orientated approach, a highly motivated team and a broad expertise in analytical development and quality control, VelaLabs is dedicated to support the customer's needs from research activities to clinical phases and up to product commercialization.

News

Foreign Trade Convention Asia 2014

Dr. Andreas Nechansky took part at the Foreign Trade Convention Asia 2014
Read more

In November 2013, VelaLabs was present at two large biotech conferences/exhibitions in Europe.

In Vienna, the BioEurope 2013 was the most successful conference ever. Exactly 1.841 companies took part in 17.874 partnering-meetings and a special event program was offering great opportunities for networking.
Read more

VelaLabs supports Special Olympics 2013

As in previous years VelaLabs is a sponsor of the Special Olympics in Austria
Read more

Press release to represent the new cooperation with Evercyte

September 2013: Vela Laboratories and Evercyte announce cooperation to provide immortalized cell lines for biosimilar characterization.
Read more

Enlarging business activities in Eastern Europe

May 2013: Enlarging business activities in Eastern Europe, VelaLabs was represented at the Bio Forum 2013 in Budapest. The partnering meetings promise fruitful collaborations with companies in Poland, Russia and Hungary.
Read more

VelaLabs joined the BIO International Convention in Chicago

April 2013: VelaLabs, Markus Fido and Klaus Hajszan, joined the BIO International Convention in Chicago. Like every year VelaLabs was represented at the worldwide re-known exhibition to force business contacts for ongoing and future protects.
Read more

VelaLabs took part at the Bio Spring Europe

March 2013: Andreas Nechansky took part at the Bio Spring Europe in Barcelona where he talked about several innovative developing projects with partners and potential clients.
Read more